PROOF-HD is the only late-stage study in Huntington’s disease targeting clinical progression; topline results expected in early Q2 2023 NAARDEN, Netherlands and WALTHAM, Mass.–(BUSINESS WIRE)–Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, today announced that the … [Read more…]

Innovative software technology enables developing provable, secure communication protocols NEW YORK–(BUSINESS WIRE)–#AdaCore—AdaCore, a trusted provider of software development and verification tools, today announced the launch of its new RecordFlux technology, designed to ease the development and security of binary communication protocols. The technology comprises a Domain Specific Language (DSL) to precisely describe complex binary data … [Read more…]

Platform Optimizes Data Use to Enhance and Accelerate Clients’ Drug Discovery SUZHOU & SHANGHAI & NEW YORK–(BUSINESS WIRE)–TandemAI today announced the release of TandemViz™ 1.0, the company’s proprietary web-based platform that provides its growing roster of drug discovery clients with a user-friendly and collaborative graphical interface to TandemAI’s suite of computational tools. The platform, which … [Read more…]

Transcarent Care Platform to incorporate Care Journey’s market-leading quality and cost insights to provide health consumers with easy-to-understand information and guidance ARLINGTON, Va.–(BUSINESS WIRE)–CareJourney, the market leader in provider quality and cost data, today announced that it was selected as the provider data partner of choice by Transcarent, the first health and care experience company … [Read more…]

DEDHAM, Mass.–(BUSINESS WIRE)–DoseSpot, a software-as-a-service (SaaS) platform that enables clinicians to electronically write and transmit prescriptions to pharmacies, has acquired the TreatRx segment of Bravado Health to strengthen and expand DoseSpot’s solution set for healthcare providers and help advance its position in the ePrescribing software integration market. The acquisition follows a strategic investment in January … [Read more…]

GenesisCare’s first MRIdian® in the U.S., one of only 28 in the U.S., will improve patient access to advanced technology that reduces the burden of treatment for patients with prostate, breast, or pancreatic tumors FORT MYERS, Fla.–(BUSINESS WIRE)–GenesisCare, one of the leading integrated cancer care providers in the United States, Australia, Spain, and the United … [Read more…]

TORONTO–(BUSINESS WIRE)–Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce the Company will be hosting its quarterly conference call on Friday, March 31, 2023 at 8:30am EST. The conference call will cover its second-quarter 2023 financial results. During the call, the Mednow team will provide an update on Mednow’s … [Read more…]

– Bicycle and Novartis will collaborate on the discovery and development of multiple targeted radioligand therapies in oncology – Bicycle will receive a $50 million upfront payment as well as potential milestones and tiered commercial royalties CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of … [Read more…]

 Gelesis has demonstrated strong demand for Plenity, helping over 200,000 people on their weight loss journeys since launch Company has filed with FDA to make Plenity available to Over the Counter (OTC), which should significantly broaden consumer access and reduce the cost to reach new members BOSTON–(BUSINESS WIRE)–$GLS #earnings–Gelesis Holdings, Inc. (NYSE: GLS) (“Gelesis” or … [Read more…]

— Distinguished biotech leaders bring expertise to support Switch Therapeutics’ ongoing growth and commitment to progressing its world class pipeline — — Craig Blanchette, Ph.D., Appointed Senior Vice President, Research — — Michael Wolfe Appointed Senior Vice President, Finance and Operations — SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Switch Therapeutics, a preclinical stage biotechnology company pioneering a … [Read more…]